Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Added: 3 months ago Source:  Radcliffe Cardiology
A new study published in JACC has evaluated the prevalence and prognostic significance of secondary tricuspid regurgitation (STR) across the spectrum of heart failure with preserved ejection fraction (HFpEF), finding that its presence is strongly associated with pulmonary vascular disease (PVD) and that different mechanisms of STR carry distinct prognoses.¹˒²This observational study analysed data… View more
Author(s): Owais Dar , Espeed Khoshbin Added: 1 year ago
Heart transplantation and left ventricular assist devices (LVADs) are crucial options for patients with advanced heart failure, but determining the right timing for intervention is key to optimizing outcomes. This webinar, moderated by Dr Owais Dar from the Royal Brompton and Harefield Hospitals, will explore the decision-making process behind patient referrals, weighing the benefits and risks of… View more
Added: 1 year ago Source:  Radcliffe Cardiology
AUTHOR: Jordan Rance; Special Editor: Greg GuilloryA new analysis sheds light on the timing of protection offered by SGLT2 inhibitors. Researchers conducted a cross-trial analysis using individual participant data from four large-scale randomized clinical trials: CANVAS (type 2 diabetes with high atherosclerotic risk, NCT01032629), CREDENCE (diabetic kidney disease, NCT02065791), DAPA-HF (heart… View more
Author(s): Johann Bauersachs Added: 11 months ago
ESC HF 25 - SCD-PROTECT shows high risk of sudden cardiac arrest (SCA) and sudden cardiac death (SCD) during early medical therapy optimization for reduced LVEF in patients with new non-ischemic cardiomyopathy or MI/CAD.Prof Johann Bauersachs (Hannover Medical School, Hannover, DE) discusses findings from the SCD–PROTECT study, an investigation of sudden cardiac arrest in patients with newly… View more
Author(s): Espeed Khoshbin, Owais Dar, Start date: Nov 05, 2024
Heart transplantation and left ventricular assist devices (LVADs) are crucial options for patients with advanced heart failure, but determining the right timing for intervention is key to optimizing outcomes. This webinar, moderated by Dr Owais Dar from the Royal Brompton and Harefield Hospitals, will explore the decision-making process behind patient referrals, weighing the benefits and risks of… View more
Author(s): Clara Bonanad Lozano , Anjay Rastogi Added: 1 year ago
Dr Anjay Rastogi (David Geffen School of Medicine UCLA, US) and Dr Clara Bonanad (University Clinical Hospital of Valencia, ES) discuss the evolving management strategies of hyperkalaemia in heart failure and chronic kidney disease, in this short video series. In this three part discussion they cover the most recent guidelines from ACC, ESC and KDIGO, real-world evidence from the recent ZORA… View more
Author(s): Mikhail Kosiborod Added: 2 years ago
ACC.24 — We are joined onsite by Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, US) to discuss the findings from the STEP HFpEF DM Trial (NCT04916470).The STEP HFpEF DM study aimed to investigate the effect of taking semaglutide 2.4mg once weekly in patients with heart failure with preserved ejection fraction (HFpEF) and diabetes mellitus type 2. The study looked at the impact of… View more